Drug Trial Radar · NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,380
Planned (sponsor's estimate)
Start
Nov 25, 2024
Primary completion
Dec 17, 2037
Study completion Dec 17, 2037
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Oct 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who received tulisokibart in certain other studies for CD or UC (called a parent study) may be able to join this study. The goals of this study are to learn about the safety of tulisokibart over time in people with CD or UC, and if people tolerate it.
Conditions
- Crohn Disease
- Colitis, Ulcerative
Interventions
TulisokibartDrug
Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered subcutaneously
Placebo to tulisokibartDrug
Placebo matching SC tulisokibart
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Experience an Adverse Event (AE)Time frame: Up to approximately 378 weeks
- Number of Participants Who Discontinue Study Treatment Due to an AETime frame: Up to approximately 364 weeks
Locations
37 sites in 7 countries. Site status is shown where the registry gives one.
Connecticut Clinical Research Institute ( Site 0297)
Bristol, Connecticut · Recruiting
St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287)
Ypsilanti, Michigan · Recruiting
BVL Research - Kansas ( Site 0292)
Liberty, Missouri · Recruiting
New York Gastroenterology Associates ( Site 0253)
New York, New York · Recruiting
GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290)
Garland, Texas · Recruiting
GI Alliance - Lubbock ( Site 0288)
Lubbock, Texas · Recruiting
Caprock Gastro Research ( Site 0293)
Lubbock, Texas · Recruiting
Southern Star Research Institute ( Site 0299)
San Antonio, Texas · Recruiting
GI Alliance - Southlake ( Site 0298)
Southlake, Texas · Recruiting
Tyler Research Institute ( Site 0294)
Tyler, Texas · Recruiting
University of Virginia Health System ( Site 0291)
Charlottesville, Virginia · Recruiting
Washington Gastroenterology - Tacoma ( Site 0295)
Tacoma, Washington · Recruiting
Hepato-Gastroenterologie HK ( Site 0700)
Hradec Králové, Czechia · Recruiting
Vojenská Nemocnice Brno-Internal department ( Site 0701)
Brno, Brno-mesto, Czechia · Recruiting
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 1002)
Nice, Alpes-Maritimes, France · Recruiting
CMC Ambroise Paré Hartmann - Institut des MICI ( Site 1003)
Neuilly-sur-Seine, Hauts-de-Seine, France · Recruiting
CHRU De Nancy - Hopital de Brabois ( Site 1001)
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France · Recruiting
Hopital Claude Huriez CHRU LILLE ( Site 1004)
Lille, Nord, France · Recruiting
ARENSIA Exploratory Medicine Georgia ( Site 1104)
Tbilisi, Georgia · Recruiting
Semmelweis Egyetem ( Site 1400)
Budapest, Hungary · Recruiting
Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórház-4. Belgyogyaszat Gasztroenterologia ( Site 1411)
Békéscsaba, Bekes County, Hungary · Recruiting
Rivermed Sp. z.o.o. ( Site 2206)
Poznan, Greater Poland Voivodeship, Poland · Recruiting
Centrum Diagnostyczno - Lecznicze Barska sp. z o.o. ( Site 2208)
Włocławek, Kuyavian-Pomeranian Voivodeship, Poland · Recruiting
Krakowskie Centrum Medyczne ( Site 2210)
Krakow, Lesser Poland Voivodeship, Poland · Recruiting
Bonifraterskie Centrum Medyczne ( Site 2207)
Lodz, Łódź Voivodeship, Poland · Recruiting
Centrum Medyczne Oporow ( Site 2212)
Wroclaw, Lower Silesian Voivodeship, Poland · Recruiting
Melita Medical Sp. z o.o. ( Site 2204)
Wroclaw, Lower Silesian Voivodeship, Poland · Active not recruiting
Przychodnia Futuremeds Wroclaw ( Site 2211)
Wroclaw, Lower Silesian Voivodeship, Poland · Active not recruiting
1 Wojskowy Szpital Kliniczny Z Poliklinika SPZOZ w Lublinie ( Site 2205)
Lublin, Lublin Voivodeship, Poland · Recruiting
Medrise Sp. z o.o. ( Site 2200)
Lublin, Lublin Voivodeship, Poland · Recruiting
EB Group Sp. Z o.o. Centrum Zdrowia MDM ( Site 2202)
Warsaw, Masovian Voivodeship, Poland · Recruiting
Vivamed Sp. z o.o. ( Site 2201)
Warsaw, Masovian Voivodeship, Poland · Recruiting
WIP Warsaw IBD Point Professor Kierkus ( Site 2209)
Warsaw, Masovian Voivodeship, Poland · Recruiting
Vita Longa Sp. Zoo ( Site 2213)
Katowice, Silesian Voivodeship, Poland · Recruiting
Sonomed Sp. z o. o. ( Site 2203)
Szczecin, West Pomeranian Voivodeship, Poland · Recruiting
MAC Research - Merseyside ( Site 3401)
Prescot, Knowsley, United Kingdom · Recruiting
Whipps Cross University Hospital ( Site 3400)
London, Waltham Forest, United Kingdom · Active not recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.